Miguel Quiliano
Overview
Explore the profile of Miguel Quiliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arica-Sosa A, Alcantara R, Jimenez-Avalos G, Zimic M, Milon P, Quiliano M
ACS Omega
. 2022 Jun;
7(23):20204-20218.
PMID: 35721990
Tuberculosis (TB) is an infectious disease caused by (). Despite being considered curable and preventable, the increase of antibiotic resistance is becoming a serious public health problem. is a pathogen...
2.
Jimenez-Avalos G, Vargas-Ruiz A, Delgado-Pease N, Olivos-Ramirez G, Sheen P, Fernandez-Diaz M, et al.
Sci Rep
. 2021 Jul;
11(1):15452.
PMID: 34326429
SARS-CoV-2 main protease is a common target for inhibition assays due to its high conservation among coronaviruses. Since flavonoids show antiviral activity, several in silico works have proposed them as...
3.
Barrenechea V, Vargas-Reyes M, Quiliano M, Milon P
Front Microbiol
. 2021 Jul;
12:682682.
PMID: 34262544
Tetracycline has positively impacted human health as well as the farming and animal industries. Its extensive usage and versatility led to the spread of resistance mechanisms followed by the development...
4.
Arias M, Quiliano M, Bourgeade-Delmas S, Fabing I, Chantal I, Berthier D, et al.
Parasitol Res
. 2020 Aug;
119(10):3503-3515.
PMID: 32772176
Malaria, babesiosis, trypanosomosis, and leishmaniasis are some of the most life-threatening parasites, but the range of drugs to treat them is limited. An effective, safe, and low-cost drug with a...
5.
Bonilla-Ramirez L, Galiano S, Quiliano M, Aldana I, Pabon A
Malar J
. 2019 Jun;
18(1):201.
PMID: 31217011
Background: The challenge in anti-malarial chemotherapy is based on the emergence of resistance to drugs and the search for medicines against all stages of the life cycle of Plasmodium spp....
6.
Bonilla-Ramirez L, Rios A, Quiliano M, Ramirez-Calderon G, Beltran-Hortelano I, Franetich J, et al.
Eur J Med Chem
. 2018 Sep;
158:68-81.
PMID: 30199706
Emergence of drug resistance and targeting all stages of the parasite life cycle are currently the major challenges in antimalarial chemotherapy. Molecular hybridization combining two scaffolds in a single molecule...
7.
Quiliano M, Pabon A, Moles E, Bonilla-Ramirez L, Fabing I, Fong K, et al.
Eur J Med Chem
. 2018 May;
152:489-514.
PMID: 29754074
Design, synthesis, structure-activity relationship, cytotoxicity studies, in silico drug-likeness, genotoxicity screening, and in vivo studies of new 1-aryl-3-substituted propanol derivatives led to the identification of nine compounds with promising in...
8.
Moles E, Galiano S, Gomes A, Quiliano M, Teixeira C, Aldana I, et al.
Biomaterials
. 2017 Sep;
145:178-191.
PMID: 28869864
Most drugs currently entering the clinical pipeline for severe malaria therapeutics are of lipophilic nature, with a relatively poor solubility in plasma and large biodistribution volumes. Low amounts of these...
9.
Alva A, Cangalaya C, Quiliano M, Krebs C, Gilman R, Sheen P, et al.
PLoS One
. 2017 Apr;
12(4):e0175646.
PMID: 28410387
Parasitic infections are generally diagnosed by professionals trained to recognize the morphological characteristics of the eggs in microscopic images of fecal smears. However, this laboratory diagnosis requires medical specialists which...
10.
Quiliano M, Pabon A, Ramirez-Calderon G, Barea C, Deharo E, Galiano S, et al.
Bioorg Med Chem Lett
. 2017 Mar;
27(8):1820-1825.
PMID: 28291694
We report the design (in silico ADMET criteria), synthesis, cytotoxicity studies (HepG-2 cells), and biological evaluation of 15 hydrazine/hydrazide quinoxaline 1,4-di-N-oxide derivatives against the 3D7 chloroquine sensitive strain and FCR-3...